Biomarker study analysis of samples from Parkinson’s, autoimmune, and inflammatory skin diseases
10.11.2025
There is growing interest to identify non-invasive biomarkers for the purposes of
(i) tracking disease progression, (ii) predicting likely onset of disease, and (iii)
finding surrogates for specific gene activity. Discovery of these biomarkers is
dramatically facilitated through the comparison of healthy individuals against
those who carry genetic variants in genes that are strongly associated with
disease risk and do or do not present with the gene of interest. This study uses
elements of this approach in profiling biobanked specimens from several
different and prevalent disease classes. The overarching goal of this study
conducted by Novartis is to investigate and profile biomarkers that reflect the
development of different diseases, namely Parkinson’s, autoimmune disorders of
the intestines, and autoimmune disorders to the skin.
